Zai Lab (ZLAB) EBT Margin (2019 - 2026)

Zai Lab (ZLAB) reported EBT Margin of 1222.59% for Q1 2026, down 117674.0% on a YoY basis from N/an in Q1 2025, and down 7654.88% sequentially from 16.18% in Q4 2025.

Zai Lab (ZLAB) EBT Margin (2019 - 2026) Analysis & Trends

Zai Lab (ZLAB) has 7 years of EBT Margin data on file, last reported at 1222.59% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 117674.0% year-over-year to 1222.59%; the trailing twelve-month figure through Mar 2026 stood at 55.44% (up 13466.0% YoY), and the FY2025 full-year result was 6000.81%, down 593637.0% from the prior year.
  • EBT Margin retreated to 1222.59% in Q1 2026, from 16.18% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 16.18% in Q4 2025 to a low of 20170.1% in Q2 2024.
  • A 5-year average of 2019.99% and a median of 99.73% in 2022 frame the typical range for EBT Margin.
  • Peak annual rise in EBT Margin reached 1564488 bps in 2025, while the deepest fall reached 509682 bps in 2025.
  • Tracing ZLAB's EBT Margin over 5 years: stood at 99.56% in 2022, then jumped by 64 bps to 35.78% in 2023, then sank by 108 bps to 74.34% in 2024, then surged by 122 bps to 16.18% in 2025, then sank by 7655 bps to 1222.59% in 2026.
  • Business Quant data shows ZLAB's EBT Margin at 1222.59% in Q1 2026, 16.18% in Q4 2025, and 5137.57% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Zai Lab 22.02 Bn 22.02 Bn 61.30 Mn -49.77%

Historic Data

Download Data
DateValue
Mar 31, 2026 -49.77%
Dec 31, 2025 -41.80%
Sep 30, 2025 -30.98%
Jun 30, 2025 -37.03%
Mar 31, 2025 -45.49%
Dec 31, 2024 -74.89%
Sep 30, 2024 -40.75%
Jun 30, 2024 -79.87%
Mar 31, 2024 -61.36%
Dec 31, 2023 -144.96%
Sep 30, 2023 -99.89%
Jun 30, 2023 -175.56%
Mar 31, 2023 -78.26%
Dec 31, 2022 -98.67%
Sep 30, 2022 -280.14%
Jun 30, 2022 -286.31%
Mar 31, 2022 -175.87%
Dec 31, 2021 -480.66%
Sep 30, 2021 -222.89%
Jun 30, 2021 -441.10%